About Instrumentation Laboratory
Our Passion. Your Results.
Innovation after innovation, our passion drives us to set new standards for in vitro diagnostic testing. We develop, manufacture and distribute instruments, related reagents and data management solutions, for hospitals around the world—at the point-of-care and in the laboratory. Our solutions include Hemostasis and Acute Care Diagnostic products and services, all designed with a common goal: to help healthcare providers enhance patient care and efficiency.
IL, integral part of Werfen since 1991
Werfen is a growing, privately held corporation that was founded in 1966 in Barcelona, Spain.
We are a worldwide leader in in vitro diagnostics (IVD) in the specialties of Hemostasis, Acute Care Diagnostics and Autoimmunity.
At present, we operate directly in nearly 30 countries and in more than 100 territories through distributors. Our R&D and production centers are located in the United States and Europe. In 2018, our consolidated sales were 1,359M€ and we had an average workforce of 5,155 people.
Sixty years of "firsts"
Our history of breakthroughs has revolutionized the world of clinical diagnostics. From the first blood gas analyzer for routine testing, to the Flame Photometer for chemistry electrolyte testing, to the invention of CO-Oximetry—the first fully automated Hemostasis analyzer to the most advanced platform for automated Hemostasis testing—our passion for innovation in R&D has made us leaders in quality in vitro diagnostic solutions. And today, more than 1.1 million patient samples are tested on IL systems each and every day.
We introduced the first direct-reading pH/blood gas analyzer (IL105) in 1959
We developed the Flame Photometer (IL143), revolutionizing chemistry electrolyte testing in 1964
We invented CO-Oximetry with the IL182 in 1968
In 1976, we introduced onboard continuous calibration (IL813), a major improvement in blood gas quality assurance
We introduced the first fully automated, mid-sized Hemostasis analyzer (ACL 810) in 1985
In 2003, we introduced iQM, a revolutionary quality control system, for use on GEM Premier blood gas analyzers
We developed the first fully automated, high-sensitivity immunoassay, chemiluminescent analyzer for Hemostasis testing (ACL AcuStar) in 2009
In 2015, we introduced unprecedented pre-analytical quality assurance in Hemostasis testing (ACL TOP Family 50 Series systems)
We introduced the first fully automated on-demand assay for HIT testing in 2016
We introduced the first Lab Automation workcell for Hemostasis testing (HemoCell) in 2016
We understand that our success comes from our employees. That’s why we give them outstanding opportunities to grow and develop. See how you can join us.